XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Japan Airlines expects no flight cancellations from A350 inspections



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Japan Airlines expects no flight cancellations from A350 inspections</title></head><body>

Updates with additional Rolls-Royce comment in paragraph 3, details on engine fuel nozzle supplier in paragraphs 13-16

By Lisa Barrington and Tim Hepher

SEOUL, Sept 6 (Reuters) -Japan Airlines 9201.T does not expect flight cancellations or delays as a result of inspections ordered by Europe's air safety regulator on engines of Airbus AIR.PA A350-1000 jets, it said on Friday.

The European Union Aviation Safety Agency said on Thursday Trent XWB-97 engines made by Rolls-Royce RR.L should be checked after an engine fire during the flight of a Cathay Pacific 0293.HK jetliner.

"Working with our customers and our supply chain, we are confident in our ability to deliver on the inspection regime," Rolls-Royce said.

Airlines had questioned Airbus and Rolls-Royce in briefings on Thursday about the availability of parts, a person briefed on the matter said.

Hong Kong-based Cathay Pacific 0293.HK cancelled a number of flightsthis week while it checked and repaired A350 engines after a Zurich-bound jet was forced to return to Hong Kong on Monday due to the engine problem, later traced to a fuel leak.

EASA gave airlines between three and 30 days to carry out visual checks and measurements on flexible fuel hose connections inside the A350-1000 engines. The smaller A350-900 variant is not subject to the order.

Japan Airlines (JAL) inspected its entire fleet of A350-1000 and A350-900 jets earlier this week, but said it would need to conduct additional inspections in accordance with the EASA directive and service instructions from Rolls-Royce.

"No issues were found on any aircraft," JAL said in a statement.

Qatar Airways, which operates the largest number of A350-1000 jets, said on Friday it was carrying out inspections after it received the directives.

Etihad Airways, which has five A350-1000 jets, said it began inspecting engines proactively before the directive was issued and continues to do so in compliance with directive.

"Etihad has discovered no issues, nor experienced any similar events with the engine, so does not anticipate any impact on its operations," it said in a statement.

British Airways and Virgin Atlantic, both of which operate A350-1000 jets, did not respond to Reuters' requests for comment.

TECHNICAL CLARITY

Industry sources said the parts are made by Parker Hannifin PH.N, a leading supplier of specialist fuel and other systems.

The Parker Aerospace unit announced in 2008 it had won contracts to supply the fuel and hydraulic systems for the A350 aircraft including equipment to handle "engine feed". Part numbers listed by EASA for inspection had the prefix PH.

Parker Hannifin did not immediately respond to a request for comment following the publication of EASA's directive.

Asked about the affected parts earlier this week, a company spokesperson said: "If called upon, we are ready to offer our support of the investigation of this matter."

Cathay Pacific said on Friday that maintenance activity on its A350 fleet "continues to progress well" and will wrap up by Saturdayas expected.

Accident investigators in Hong Kong, where Cathay is based, are still investigating the incident.

Broker Jefferies said in a note to clients on Friday it considered the engine issue was unlikely to be widespread, and said no significant regulatory action had been taken.

"With the faulty part in question now confirmed as a fuel nozzle/hose, any work required on the engines, if found to be faulty, should be fairly limited and a quick fix... This implies only minor costs for Rolls-Royce," it said.



Additional reporting by Maki Shiraki, Andrew Mills, Allison Lampert and Joanna Plucinska; Editing by David Goodman, Emelia Sithole-Matarise and Jan Harvey

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.